Credits: Canva
For over 15 years, Dr Anthony Shum, a pulmonologist at the University of California, San Francisco has been studying a rare genetic disorder called the COPA Syndrome. It stands for coatomer subunit alpha and is a rare, inherited disorder that affects the lungs, joint, and kidney. The National Organization for Rare Disorder also notes that it is a genetic autoimmune disorder that is caused by mutations in the COPA gene. This disease affects families unpredictably—some individuals with the mutation develop severe lung damage early in life, while others remain completely healthy. Now, Shum’s team has discovered a protective genetic variant that may offer new hope for treatment.
Researchers found that some relatives of COPA Syndrome patients stayed healthy despite carrying the same COPA gene mutation that causes the disease. The key difference? These unaffected individuals had a protective version of another gene called HAQ-STING.
When scientists introduced HAQ-STING into diseased lung cells from COPA patients, the cells returned to a balanced state, suggesting that this gene could be used as a therapy.
“We really think HAQ-STING could be a gene therapy tool and a step toward a cure,” said Shum, whose findings were published in the Journal of Experimental Medicine.
Shum’s journey into COPA Syndrome research began in 2011 when he treated a young woman, Letasha, who had severe lung bleeding. Her mother, Betty Towe, mentioned that Letasha’s sister, Kristina, had suffered from similar symptoms. Over the years, Betty had taken both daughters on a four-hour trip to UCSF for treatment. After tracing their family history, Shum discovered that their distant relatives in Texas and Oakland also had lung problems and arthritis. In 2015, Shum, along with scientists from Baylor College of Medicine and Texas Children’s Hospital identified the COPA gene mutation. They realized that it was the common factor behind the illness. However, only some of the 30 individuals with the mutation actually developed symptoms, leaving a major question unanswered.
It was established that it occurs when a mutated COPA gene causes another gene STING to go overdrive. The STING that helps fight infections in COPA patients, remain permanently active, which leads to chronic inflammation that damages the lungs, kidneys, and joints. In 2020, while studying STING’s role in the disease, researchers discovered a key variation: HAQ-STING. This version of STING, present in about one-third of the population, appeared to neutralize the harmful effects of the COPA mutation.
To confirm their theory, the scientists needed both affected and unaffected family members to participate in the testing. Letasha, Kristina and Betty immediately volunteered. The researchers then analyzed DNA samples from 26 COPA patients and their healthy relatives. They also conducted CT scans and blood tests to ensure that unaffected members did not have any hidden symptoms. When the findings were all clear, it was revealed that all the healthy individuals had HAQ-STING, while none of the COPA patients did. This was the first known case of a common gene variant completely protecting against a severe genetic disease.
Encouraged by this discovery, researchers tested HAQ-STING’s effects in a lab setting. They introduced it into diseased lung cells from COPA patients, and the cells returned to normal function.
Shum believes HAQ-STING could lead to game-changing treatments, including:
Before publishing their findings, Shum called Betty with the news—her own HAQ-STING gene had protected her from the disease. He also informed Letasha and Kristina, who were overwhelmed with relief and joy.
“We always believed Dr. Shum would get to the bottom of it,” said Letasha. “This discovery is going to change lives.”
Credit: AI generated image
Convenience foods have become the defining feature of urbanization. From ready-to-eat breakfasts to microwavable dinners and takeaway lunches, packaged food fits into all our lives.
But behind this convenience, what lies underneath are the tiny plastic particles, also referred to as microplastics, which are accentuating health concerns across the globe. Unknowingly, these microplastics are seeping through the plastic cutlery, food packaging, etc., potentially into our bodies. Plastics have been widely used for ages due to their higher affordability, durability, and extensive applications in various industries.
As per a recent literature quoted by Zhang et al. 2025, only about 20% of the plastic waste produced is recycled, whereas the rest is either abandoned in landfills or dispersed into the environment. Microplastics are the new emerging pollutant category in the modern era, raising prominent concerns in both health & environmental contexts. As per scientific literature, microplastics are plastic fragments with a diameter of less than 5mm.
Plastic food packaging dominates the global food system, since it can be designed in any form (container, wrapper, pouch, etc) while keeping food fresh for longer periods.
Microplastics are released from food packaging(s), especially when they are exposed to prolonged heat, abrasive forces, and undue environmental stresses. Heating and/or reheating food in plastic containers or choosing to decant packaged food commodities in plastic containers and maintaining them under unfavorable circumstances can all increase the likelihood of microplastic release.
Bottled water has also proven to release thousands of microplastic particles into the water they contain when exposed to sunlight/ heat. We never give a thought to such bottles being sold by the roadside vendors, wherein these plastic bottles are hung for indefinite days on that kiosk.
Those bottles are in constant light exposure all day without even pondering about the ill effects it may cause to the consumers. Similarly, single-use tea bags have also been shown to release billions of microplastics when steeped in hot water. These findings highlight a troubling paradox that products marketed for convenience and safety may be introducing new risks that consumers never thought about.
The health implications of ingesting microplastics remain an active area of research, but early findings are enough to raise concerns. Studies have demonstrated microplastics in human blood, lungs, and even placental tissue. This suggests that upon ingestion, these particles may not simply pass through the body. Instead, they would accumulate in tissues or interact with biological systems in ways that are not yet fully explored.
One of the major health implications pertaining to microplastic ingestion is inflammation. These particles can trigger irritation in tissues, eventually impacting the immune responses.
Plastics often contain additives in the form of plasticizers, etc., which may disrupt hormone function and impair the normal cellular function.
Infants and children are more often vulnerable as their food is also packed in plastic packaging or containers (like plastic sippers, feeding bottles, baby food pouches, etc.), raising long-term exposure risk during critical stages of growth.
The issues relating to plastic usage also reflect a broader tension in the modern era, where convenience seems to intersect with health! For people or families juggling work and financial burdens, avoiding packaged foods mostly sounds unrealistic.
Still, some small and consistent actions can help us reduce the exposure to microplastics, like opting for glass or paper packaging wherever possible. Avoiding heating food in plastic containers or opting for biodegradable packaging options could prove to be beneficial in the future. Though microplastics are invisible to our naked eyes, what we do next to curb them would help us shape a healthy future.
Credit: Canva
Are you aware? Scientific insights are helping people of all ages understand heart health better and take the right steps at the right time. Heart health is no longer a concern only for older adults. So, people across all age groups are at risk of developing Heart Disease because of changing lifestyles, stress, and unhealthy habits.
So, here, science plays a pivotal role. With the help of improved research, advanced diagnostics, and increased awareness, science is helping individuals understand their risk factors early and take preventive steps before serious complications arise.
Heart disease is commonly seen in people of all age groups. So, according to scientific research, heart disease develops gradually over time. Early markers such as high cholesterol, blood pressure, and poor lifestyle habits can begin affecting the body even in the 20s or 30s and lead to a poor quality of life.
Today, advanced screening tools and regular health check-ups make it possible to detect these risks early and initiate timely intervention.
For youngsters, science tends to highlight the importance of prevention through healthy eating, regular exercise, quitting smoking, and alcohol. When it comes to middle-aged adults, monitoring conditions like diabetes, hypertension, and cholesterol can help save the heart.
In older adults, it will be necessary to manage existing conditions like diabetes and high blood pressure and prevent heart attacks or stroke.
Moreover, you will also have to understand that genetics also plays an important role. Scientific advancements help doctors identify individuals with a family history of heart disease and guide them with individualized treatment care plans for outcomes.
Currently, you will be surprised to know that modern science has also shed light on the importance of lifestyle in maintaining heart health. So, opting for wearable devices, health apps, and regular screenings helps track heart rate, physical activity, and prevent any concerning heart problems in people.
Robotic surgeries are now enabling heart patients to recover more quickly and provide benefits such as shorter hospital stays, minimal blood loss, and are extremely safe.
Hence, by understanding risk factors, adhering to healthy habits, and undergoing regular check-ups as advised by the doctor on a yearly basis, individuals can take control of their heart health.
Credit: Canva
Inflammatory Bowel Disease (IBD) is no longer a rare disease in India. Over the last decade, gastroenterologists across the country have seen a steady rise in patients suffering from ulcerative colitis and Crohn’s disease, the two main forms of IBD.
Yet despite increasing numbers, awareness about the disease remains surprisingly poor. Many patients continue to suffer silently for years because their symptoms are misunderstood, ignored, or mistaken for other common intestinal illnesses.
IBD is a chronic inflammatory condition of the digestive tract caused by an abnormal immune response. Unlike routine stomach infections, it is not simply a “bad stomach” or food-related issue.
Patients commonly experience persistent diarrhea, blood in stools, abdominal pain, weight loss, fatigue, and loss of appetite. In children and young adults, it may also affect growth, nutrition, and quality of life.
Unfortunately, in India, these symptoms are often initially treated as recurrent food poisoning, piles, irritable bowel syndrome, or intestinal infections. Many patients repeatedly receive antibiotics without proper evaluation.
Some even undergo unnecessary treatments before finally reaching a specialist. This delay in diagnosis can lead to severe complications, including intestinal strictures, fistulas, malnutrition, hospitalization, and the need for surgery.
One major reason for underdiagnosis is the overlap of symptoms with intestinal tuberculosis, which remains common in India. Distinguishing Crohn’s disease from intestinal TB can sometimes be extremely challenging, even for experienced doctors.
As a result, some patients are unnecessarily started on anti-tubercular therapy while their actual disease continues to progress silently.
Another important issue is stigma. Many patients hesitate to discuss bowel-related symptoms openly due to embarrassment. Young individuals, especially, may ignore rectal bleeding or chronic diarrhea for months, assuming it is temporary or stress-related. Social media misinformation and self-medication further worsen the problem.
The good news is that treatment options for IBD have improved tremendously. Modern therapies, including biologic medications, advanced endoscopy, nutritional therapy, and personalized treatment strategies, now allow many patients to live completely normal and productive lives. Early diagnosis is the key.
Persistent bowel symptoms lasting more than a few weeks should never be ignored, especially if associated with bleeding, weight loss, anemia, or nighttime symptoms.
India urgently needs greater public awareness about IBD. Equally important is timely referral to gastroenterologists and access to proper diagnostic facilities such as colonoscopy, imaging, and histopathology. IBD is not merely a stomach problem — it is a lifelong immune-mediated disease that requires understanding, long-term care, and compassionate management.
© 2024 Bennett, Coleman & Company Limited